Skip to main content
Equibles
DCTH logo

DCTH · Delcath Systems, Inc. · Metrics

Track DCTH — free

Use DCTH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DCTH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.75 +0.24 (+1.65%) At close · Oct 27 Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$511.81M
Shares
34.70M
Volume · Oct 27 245.08K Avg daily vol (3M) 466.69K

DCTH metrics

92 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$14.75
Market cap
$511.81M

Price action

20 metrics
Price change (1W)
-0.1%
Price change (30D)
-6.7%
Price change (3M)
+27.7%
Price change (6M)
+39.8%
Price change (YTD)
+46.0%
Price change (1Y)
+47.6%
Trailing year
Price change (5Y)
+37.6%
52-week high
$17.36
52-week low
$8.19
Change from 52-week high
-15.0%
Change from 52-week low
+80.1%
Annualized volatility
50.0%
Annualized volatility (3M)
60.6%
Beta
1.4
RSI (14D)
45.0
Price vs SMA 50
-6.7%
Price vs SMA 200
+20.1%
Avg volume (3M)
466,689
Relative volume
0.5
Average dollar volume
$7.31M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
34.70M

Valuation

12 metrics
P / E (TTM)
1,475.0
Trailing earnings · reciprocal yield 0.1%
PEG ratio
—
EV / revenue
4.9×
reciprocal yield 20.6%
EV / EBITDA
—
EV / EBIT
—
P / sales
5.4×
reciprocal yield 18.6%
P / book
4.2
reciprocal yield 23.7%
FCF yield
3.4%
TTM · current market cap
Buyback yield
1.8%
P / FCF
29.2
reciprocal yield 3.4%
P / operating cash flow
26.1
reciprocal yield 3.8%
Earnings yield
0.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
15.9×
reciprocal yield 6.3%
EV / revenue historical average (5Y)
16.2×
reciprocal yield 6.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-09
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
87.1%
Operating margin
-1.9%
Trailing 12 months
Net margin
0.6%
Gross profit (TTM)
$83.06M
Operating profit (TTM)
−$1.81M
Net income (TTM)
$532,000
Trailing 12 months
Diluted EPS (TTM)
$0.01
FCF margin
18.3%
Effective tax rate
58.8%

Per share

11 metrics
Revenue per diluted share (TTM)
$2.46
Gross profit per diluted share (TTM)
$2.14
Operating profit per diluted share (TTM)
$-0.05
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.01
Operating cash flow per diluted share (TTM)
$0.49
Free cash flow per diluted share (TTM)
$0.44
Capital expenditures per diluted share (TTM)
$0.05
R&D per diluted share (TTM)
$0.97
Stock compensation per diluted share (TTM)
—
Book value per share
$3.21

Growth

11 metrics
Revenue growth YoY
+20.6%
Year over year
Net income growth YoY
-1.1%
Revenue (TTM)
$95.42M
Trailing 12 months
EPS growth YoY
+0.0%
Shares change YoY
-1.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+215.3%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
0.4%
Return on assets
0.4%
Debt / equity
0.0
Current ratio
9.8
EBITDA (TTM)
—
Free cash flow (TTM)
$17.51M
Quick ratio
8.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
-1.0%
Trailing 12 months
Net cash
$47.52M
Latest balance sheet
Cash & equivalents
$47.52M
Total assets
$137.02M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$19.59M
Capital expenditures (TTM)
$2.08M
R&D (TTM)
$37.56M
SG&A (TTM)
$47.32M
Stock compensation (TTM)
—
R&D / revenue
39.4%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
121
13F filer change QoQ
-1
Institutional ownership
51.6%
Conviction holders (share of 13F filers)
1.7%
Crowding (high-turnover and private-fund holders)
16.7%
Private-fund adviser ownership
15.7%
Active holders' share change QoQ
+0.5%
Holder tenure
8.9
Price vs estimated holder cost
+10.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
10.5%

Short interest

3 metrics
Short interest
5.4%
Latest settlement · 6.2 days to cover
Days to cover
6.2d
Short-squeeze score
57 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 872912 CUSIP 24661P807 13F (30d) 22 filings 22 filers Visit website Investor relations